Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Tobacco harm reduction in the real world: has the availability of snus in Norway increased smoking cessation?

Tobacco harm reduction in the real world: has the availability of snus in Norway increased... Purpose – In Norway, snus (low nitrosamine smokeless tobacco) is allowed to compete with cigarettes for market share, and over the past decades the prevalence of snus users has increased as the prevalence of smokers has decreased. The author has aimed to sum up the findings from research that has tried to identify the role of snus in smoking cessation and how availability to snus in Norway has affected the magnitude of concomitant use of snus and cigarettes. Design/methodology/approach – Relevant results from Norwegian studies are presented, and, if possible, compared to findings from studies conducted in other countries. Findings – Snus is reported by ever‐smokers to be the most preferred method for quitting, and former smokers make up the largest segment of Norwegian snus users. The quit rate for smoking is consistently observed to be higher for snus users than for smokers who have no experience of use of snus. Moreover, those using snus are more likely to have quit smoking completely or considerably reduced their cigarette smoking than users of medicinal smoking cessation products. The increase in snus use among men in Norway has not been paralleled by an increase in dual use of snus and cigarettes. Research limitations/implications – The results observed in Norway might not be extrapolated to other countries that do not have the same history of use of snus. Practical implications – The replacement of cigarettes by snus has been the most typical pattern of use in Norway, and the availability of snus may have been beneficial to public health. Originality/value – Besides neighbouring Sweden, Norway is the only country in the eurozone with a tradition of snus use. Knowledge about the pattern of snus use in these countries is relevant for policymakers when deciding the legal status of snus in the EU. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drugs and Alcohol Today Emerald Publishing

Tobacco harm reduction in the real world: has the availability of snus in Norway increased smoking cessation?

Karl Erik Lund
Drugs and Alcohol Today , Volume 13 (2): 10 – Jun 7, 2013
Download PDF
10 pages

Loading next page...
 
/lp/emerald-publishing/tobacco-harm-reduction-in-the-real-world-has-the-availability-of-snus-jJ0z60c7Oz
Publisher
Emerald Publishing
Copyright
Copyright © 2013 Emerald Group Publishing Limited. All rights reserved.
ISSN
1745-9265
DOI
10.1108/DAT-02-2013-0006
Publisher site
See Article on Publisher Site

Abstract

Purpose – In Norway, snus (low nitrosamine smokeless tobacco) is allowed to compete with cigarettes for market share, and over the past decades the prevalence of snus users has increased as the prevalence of smokers has decreased. The author has aimed to sum up the findings from research that has tried to identify the role of snus in smoking cessation and how availability to snus in Norway has affected the magnitude of concomitant use of snus and cigarettes. Design/methodology/approach – Relevant results from Norwegian studies are presented, and, if possible, compared to findings from studies conducted in other countries. Findings – Snus is reported by ever‐smokers to be the most preferred method for quitting, and former smokers make up the largest segment of Norwegian snus users. The quit rate for smoking is consistently observed to be higher for snus users than for smokers who have no experience of use of snus. Moreover, those using snus are more likely to have quit smoking completely or considerably reduced their cigarette smoking than users of medicinal smoking cessation products. The increase in snus use among men in Norway has not been paralleled by an increase in dual use of snus and cigarettes. Research limitations/implications – The results observed in Norway might not be extrapolated to other countries that do not have the same history of use of snus. Practical implications – The replacement of cigarettes by snus has been the most typical pattern of use in Norway, and the availability of snus may have been beneficial to public health. Originality/value – Besides neighbouring Sweden, Norway is the only country in the eurozone with a tradition of snus use. Knowledge about the pattern of snus use in these countries is relevant for policymakers when deciding the legal status of snus in the EU.

Journal

Drugs and Alcohol Today – Emerald Publishing

Published: Jun 7, 2013

Keywords: Tobacco; Smokeless; Snus; Cigarettes; Cessation; Dual use; Norway

References

  • The acute effect of Swedish‐style snus on cigarette craving and self‐administration in male and female smokers
    Barrett, S.P.; Campbell, M.L.; Temporale, K.; Good, K.B.P.
  • Smokeless tobacco as a nicotine delivery device; harm or harm reduction?
    Benowitz, N.L.
  • Prevalence of trial of snus products among adult smokers
    Biener, L.; McCausland, K.; Curry, L.; Cullen, J.
  • Are smokers only using cigarettes? Exploring polytobacco use among an adult population
    Bombard, J.M.; Pederson, L.L.; Nelson, D.E.; Malarcher, A.M.
  • Outcome of a tobacco use cessation randomized trial with high‐school students
    Burton, D.; Chakravorty, B.; Weeks, K.; Flay, B.R.; Dent, C.; Stacy, A.; Sussman, S.
  • Randomized crossover trial of the acceptability of snus, nicotine gum and Zonnic therapy for smoking reduction in heavy smokers
    Caldwell, B.; Burgess, C.; Crane, J.
  • A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit
    Carpenter, M.J.; Gray, K.M.
  • Socio‐demographic, lifestyle and health characteristics among snus users and dual tobacco users in Stockholm County, Sweden
    Engström, K.; Magnusson, C.; Galanti, M.R.
  • Snus as a smoking cessation aid: a randomized placebo‐controlled trial
    Fagerström, K.O.; Rutqvist, L.E.; Hughes, J.R.
  • Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost‐Pineda, K.; Appleton, S.; Fisher, M.; Fox, K.; Gaworski, C.L.
  • Are Australian smokers interested in using low‐nitrosamine smokeless tobacco for harm reduction?
    Gartner, C.E.; Jimenez‐Soto, E.V.; Borland, R.; O'Connor, R.J.; Hall, W.D.
  • Swedish snus for tobacco harm reduction: an epidemiological modeling study
    Gartner, C.E.; Hall, W.D.; Vos, T.; Bertram, M.Y.; Wallace, A.L.; Lim, S.S.
  • Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden
    Gilljam, H.; Galanti, M.R.
  • Patterns of snus and cigarette use: a study of Norwegian boys followed from age 16 to 19
    Grøtvedt, L.; Forsén, L.; Stavem, K.; Graff‐Iversen, S.
  • Smokeless tobacco use: harm reduction or induction approach?
    Hatsukami, D.K.; Lemmonds, C.; Tomar, S.L.
  • Changing smokeless tobacco products. New tobacco‐delivery systems
    Hatsukami, D.K.; Ebbert, J.O.; Feuer, R.M.; Stepanov, I.; Hecht, S.S.
  • Tal om tobakk 1973‐2009 Report
    Helleve, A.; Weiseth, A.H.; Lindbak, R.L.
  • Snus does not save lives: quitting smoking does!
    Holm, L.E.; Fisker, J.; Larsen, B.I.; Puska, P.; Halldórsson, M.
  • Methods for Evaluating Tobacco Control Policies
    International Agency for Research on Cancer (IARC)/World Health Organization
  • Randomized, placebo‐controlled, double‐blind trial of Swedish snus for smoking reduction and cessation
    Joksic, G.; Spasojevic‐Tisma, V.; Antic, R.; Nilsson, R.; Rutqvist, L.E.
  • Impact of differing definitions of dual tobacco use: implications for studying dual use and call for operational definitions
    Klesges, R.C.; Ebbert, J.O.; Morgan, G.D.; Sherill‐Mittleman, D.; Asfar, T.; Talcott, W.G.; DeBon, M.
  • Effect of oral snus and medical nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasability study
    Kotlyar, M.; Hertsgaard, L.A.; Lindgren, B.R.; Jensen, J.A.; Carmella, S.G.; Stepanov, I.; Murphy, S.S.; Hecht, S.S.; Hatsukami, D.K.
  • Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
    Kozlowski, L.T.; Strasser, A.A.; Giovino, G.A.; Erickson, P.A.; Terza, J.V.
  • The relationship between snus use and smoking cognitions
    Larsen, E.; Rise, J.; Lund, K.E.
  • Tobacco, nicotine and harm reduction
    Le Houezec, J.; McNeill, A.; Britton, J.
  • The relative risks of a low‐nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts
    Levy, D.T.; Mumford, E.A.; Cummings, K.M.; Gilpin, E.A.; Giovino, G.; Hyland, A.; Sweanor, D.; Warner, K.E.
  • Smoking cessation among daily smokers aged 45‐49 years: a longitudinal study in Malmö, Sweden
    Lindström, M.; Isacsson, S.O.
  • Perceptions of the relative harmfulness of snus among Norwegian GPs and their effect on the tendency to recommend snus in smoking cessation
    Lund, I.; Scheffels, J.
  • A Tobacco‐Free Society or Tobacco Harm Reduction? Which Objective is Best for the Remaining Smokers in Scandinavia? SIRUS‐Report 6/2009
    Lund, K.E.
  • Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes
    Lund, K.E.
  • Patterns of dual use of snus and cigarettes in a mature snus market presentation
    Lund, K.E.; McNeill, A.
  • Patterns of dual use of snus and cigarettes in a mature snus market
    Lund, K.E.; McNeill, A.
  • The use of snus for quitting smoking compared with medicinal products
    Lund, K.E.; McNeill, A.; Scheffels, J.
  • The association between use of snus and quit rates for smoking: results from seven Norwegian cross‐sectional studies
    Lund, K.E.; Scheffels, J.; McNeill, A.
  • Norwegian Tobacco Statistics 1973‐2006 Sirus skrifter nr 3
    Lund, M.; Lindbak, R.
  • Patterns of tobacco use: a 10‐year follow‐up study of smoking and snus habits in a middle‐aged Swedish population
    Lundqvist, G.; Sandström, H.; Öhman, A.; Weinehall, L.
  • Nicotine delivery and subjective effects of Swedish snus compared with 4 mg nicotine polacrilex chewing gum
    Lunell, E.; Curvall, M.
  • Steady‐state nicotine plasma levels following use of four different types of Swedish snus compared with 2‐mg Nicorette chewing gum: a crossover study
    Lunell, E.; Lunell, M.
  • Reducing harm from tobacco use
    McNeill, A.; Munafó, M.R.
  • Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA
    Mejia, A.B.; Ling, P.M.; Glantz, S.A.
  • Who is using snus? Time trends, socioeconomic and geographic characteristics of snus users in the ageing Swedish population
    Norberg, M.; Malmberg, G.; Ng, N.; Brostrom, G.
  • Changing patterns of tobacco use in a middle‐aged population – the role of snus, gender, age, and education
    Norberg, M.; Lundqvist, G.; Nilsson, M.; Gilljam, H.; Weinehall, L.
  • A grounded theory of snuff‐dipping behavior in a Norwegian population
    Nordby, K.; Wood, R.T.A.
  • Relative harm of snus and cigarettes: what do Norwegian adolescents say?
    Øverland, S.; Hetland, J.; Aarø, L.E.
  • Role of snus in initiation and cessation of tobacco smoking in Sweden
    Ramström, L.; Foulds, J.
  • Dual use after uptake of snus among daily smokers: how does it influence the conditions for subsequent cessation of smoking?
    Ramström, L.M.; Wikmans, T.
  • Impact of smokeless tobacco use on smoking in northern Sweden
    Rodu, B.; Stegmayr, B.; Nasic, S.; Asplund, K.
  • Evolving patterns of tobacco use in northern Sweden
    Rodu, B.; Stegmayr, B.; Nasic, S.; Cole, P.; Asplund, K.
  • Contrasting snus and NRT as methods to quit smoking. An observational study
    Scheffels, J.; Lund, K.E.; McNeill, A.
  • Health effects of smokeless tobacco products
    Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)
  • The decline of smoking in northern Sweden
    Stegmayr, B.; Eliasson, M.; Rodu, B.
  • The association of snus and smoking behavior: a cohort analysis of Swedish males in the 1990s
    Stenbeck, M.; Hagquist, C.; Rosén, M.
  • Population tobacco control interventions and their effects on social inequalities in smoking: systematic review
    Thomas, S.; Fayter, D.; Misso, K.; Petticrew, M.; Sowden, A.; Whitehead, M.; Worthy, G.
  • Are smokers receptive to using smokeless tobacco as a substitute?
    Timberlake, D.S.
  • A content analysis of Camel Snus advertisements in print media
    Timberlake, D.S.; Pechmann, C.; Tran, S.Y.
  • Snuff use and smoking in US men: implications for harm reduction
    Tomar, S.L.
  • Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys
    Tomar, S.L.; Alpert, H.R.; Connolly, G.N.
  • Is smokeless tobacco use an appropriate public health strategy for reducing societal harm from cigarette smoking?
    Tomar, S.L.; Fox, B.J.; Severson, H.H.
  • Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation
    Wetter, D.W.; McClure, J.B.; de Moor, C.; Cofta‐Gunn, L.; Cummings, S.; Cincripini, P.M.; Gritz, E.R.
  • Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results?
    Zhu, S.H.; Wang, J.B.; Hartman, A.; Zhuang, Y.; Gamst, A.; Gibson, J.T.; Gilljam, H.; Galanti, M.R.